Autopsy report · NCT05131776

EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.

“Inadequate funding”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 2 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

Chinese University of Hong Kong

Sponsor type

University, hospital or other

Conditions

Pancreatic Cancer; Endoscopic Ultrasound

Interventions

EUS-guided oncosil injection

Participants

2

Sites

1

Countries

Hong Kong

Trials that died the same way

• Use Of Virtual Reality For Pain Control in Dermatological Bedside Procedures
  “Lack of funding” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.